Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $23
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $22 to $23.
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $22 to $23.